Norway’s Princess Mette-Marit undergoes successful lung transplant

successful lung – Princess Mette-Marit of Norway, 52, has undergone a lung transplant for chronic pulmonary fibrosis, with doctors saying the surgery at Oslo University Hospital Rikshospitalet went well so far. She is expected to remain at the hospital for several weeks.

By June 17, the news had moved from waiting to surgery for Princess Mette-Marit of Norway. The royal family said the 52-year-old underwent a lung transplant at Oslo University Hospital Rikshospitalet to treat a progressive lung disease called chronic pulmonary fibrosis. and that the transplant surgery had been successful.

The statement offered a rare glimpse into the early medical phase after such an operation. “We are delighted that everything has progressed well so far,” Are Holm, professor of medicine at the university and senior consultant and respiratory specialist at Rikshospitalet, said.

Holm also said the princess will remain at the hospital for several weeks, describing that as “standard practice for all recent transplant recipients.” The details matter: after a transplant, the first stretch is often where close monitoring is most critical.

Chronic pulmonary fibrosis is a condition that worsens over time. according to the Mayo Clinic. as lung tissue becomes damaged and scarred. The clinic describes how thickened, stiff lung tissue makes it harder for the lungs to work properly. Damage from pulmonary fibrosis cannot be repaired. the Mayo Clinic adds. even as medicines and therapies may sometimes slow the rate of fibrosis. ease symptoms. and improve quality of life. For some patients, a lung transplant can be an option.

The royal family had already signaled the severity before the operation. In a statement on June 5, announcing that the princess was placed on the lung transplant waiting list, the chronic lung disease was called “serious” and “life-threatening.”

Physicians and medical centers also outline what patients may experience. The Cleveland Clinic lists symptoms of pulmonary fibrosis including shortness of breath. breathing in short. shallow spurts. dry cough. fatigue. weight loss. clubbed fingers. and bluish. gray. or white skin around the lips. eyes. or nails.

The cause is often uncertain. In most cases, Cleveland Clinic explains, the specific trigger is unknown. Experts believe it can occur when lungs don’t heal properly after damage or inflammation. Possible contributors can include environmental exposures, certain diseases, medications or treatments, and smoking, the clinic adds.

Life expectancy is difficult to predict and can vary by form of the disease. Cleveland Clinic notes that for idiopathic pulmonary fibrosis—the most common form—life expectancy is three to five years, while adding that life expectancies for people with PF have been getting longer in recent years.

Even when the goal is a better future, the risks do not disappear. Mayo Clinic notes that while a lung transplant can improve quality of life and help someone live longer. the surgery can involve complications such as rejection and infection. Both Mayo Clinic and the Cleveland Clinic advise patients to discuss treatment options with their doctors.

The medical story here runs on a clear timeline: June 5 brought placement on the transplant waiting list. June 17 brought the transplant itself. and Holm’s statement points to weeks of recovery and monitoring at Rikshospitalet. For a disease described as serious and life-threatening. the shift from waiting to surgery is the turning point—followed by the hard part. staying in a hospital long enough to make sure the new lungs can take hold.

Norway princess lung transplant Mette-Marit chronic pulmonary fibrosis Rikshospitalet Oslo University Hospital pulmonary fibrosis symptoms lung transplant waiting list